Similar to other businesses operating in the country, the research-based pharmaceutical industry is seeking economic relief from the government to help them recover from the ill effects of the COVID-19 pandemic.
The Pharmaceutical and Healthcare Association of the Philippines (PHAP), representing the research-based providers of life-saving medicines, vaccines and diagnostics in the country, said the pharmaceutical industry is confronting the burden of providing quality medicines to Filipinos while battling market contractions.
